Skip to main content
Cantargia logo

Cantargia — Investor Relations & Filings

Ticker · CANTA ISIN · SE0023312970 LEI · 549300GKWRT7RXI4VS85 ST Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2022-08-31 Declaration of Voting R…
Country SE Sweden
Listing ST CANTA

About Cantargia

https://cantargia.com/en/

Cantargia is a biotechnology company that develops antibody-based therapies targeting the interleukin-1 receptor accessory protein (IL1RAP). This protein is involved in signaling pathways that can drive cancer and inflammatory diseases. The company's lead asset, nadunolimab (CAN04), is a clinical-stage antibody under investigation for the treatment of various forms of cancer, including pancreatic cancer. Cantargia also developed the CAN10 program, an antibody targeting IL1RAP for autoimmune and inflammatory conditions, which was acquired by Otsuka Pharmaceutical.

Recent filings

Filing Released Lang Actions
Nytt antal aktier och röster i Cantargia
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release dated August 31, 2022, announcing a change in the total number of shares and votes following a rights issue ('förtrydesemissionen'). It explicitly states the new total count (166,987,895 shares and votes) and mentions that this information is being made public according to financial instrument trading laws. This type of announcement, detailing a change in the capital structure due to issuance or repurchase activities, directly aligns with the 'Share Issue/Capital Change' definition. Code mapping: - 'CAP' (Capital/Financing Update) is possible, but 'SHA' (Share Issue/Capital Change) is more specific for changes resulting from an issuance. - It is not an ER (Earnings Release), IR (Interim Report), or 10-K (Annual Report). Therefore, the most appropriate classification is SHA.
2022-08-31 Swedish
New number of shares and votes in Cantargia
Share Issue/Capital Change Classification · 99% confidence The document is a short press release dated August 31, 2022, announcing a change in the total number of outstanding shares and votes following a recently completed rights issue. This directly relates to a change in the company's capital structure (share count). According to the definitions, 'Share Issue/Capital Change (Code: SHA)' covers announcements regarding new share issues or capital changes. Although the rights issue itself was announced earlier, this document confirms the final resulting share count, which falls under SHA. It is too specific for the general 'RNS' fallback and is not a report announcement (RPA) as it contains substantive information about the new share count, not just a link to a report.
2022-08-31 English
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'DELÅRSRAPPORT' (Interim Report) and covers the period 'Januari - Juni 2022'. It contains comprehensive financial data, including income statements, balance sheet items (liquidity, equity ratio), and detailed management commentary on business performance, clinical trial progress, and future outlook. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H2 2022
2022-08-30 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT' and covers the period 'January - June 2022'. It contains detailed financial data, including net sales, operating loss, loss per share, and equity/assets ratios for the specified period. It also includes a 'Chief Executive's Review' and detailed descriptions of the company's clinical studies and project portfolio. This meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial statements and analysis for a period shorter than a full fiscal year. H2 2022
2022-08-30 English
Major Shareholding Notification 2022
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for a specific holder (Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension) in CANTARGIA AB. It explicitly lists the 'Before the transaction' and 'After the transaction' share quantities and voting rights percentages, culminating in a 'Resulting distribution of total holdings'. The key phrase 'Reason for major shareholding notification' strongly indicates this is a mandatory disclosure when ownership crosses a specific threshold (here, 5%). This aligns perfectly with the definition of Major Shareholding Notification (MRQ). The document length is short (3680 chars), but the content is the core notification itself, not an announcement of a report.
2022-08-17 English
Major Shareholding Notification 2022
Major Shareholding Notification Classification · 99% confidence The document explicitly details a change in shareholding quantity and percentage for a specific instrument (Aktier SE0018397259) by a holder (Swedbank Robur Fonder AB), noting the 'Before the transaction' and 'After the transaction' figures, and stating the 'Reason for major shareholding notification'. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing thresholds. The appropriate code is MRQ.
2022-08-12 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.